Regulatory & Legal

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

NASDAQ-listed Bio Green Med Solution abandons its biopharma roots for fire safety, slashing losses but facing new questions about its long-term survival.

As The Hanover prepares its Q1 2026 report, investors watch to see if it can sustain momentum amid inflation, high rates, and catastrophe risks.

In a stunning rebuke, a judge warns of 'criminal consequences' as a charity's fight for survival puts government secrecy and accountability on trial.

James Madison University earns its third national seal for democratic planning, showcasing a data-driven model for boosting youth voter participation.

With a 25-year tenure, new CEO Ann Fairchild will leverage her strategic and legal expertise to steer Siemens through America's industrial revival.

First Tech hires former Federal Reserve counsel Steven Wright as CLO, a strategic move to navigate post-merger growth and complex financial regulations.

Biotech firm Carbios confirms its landmark recycling plant, appointing a new deputy CEO while battling legal challenges from a former executive.

A new survey reveals a sharp decline in driving behavior, with many parents now saying they'd trust an autonomous car over their own teen driver.

JeffSTAT pilot Mike Moore hits a rare 3,000-transport milestone, highlighting a career of dedication and the critical role of air medical teams.

New research shows government digital services are widely available but rarely used, as legacy systems and low adoption create an invisible barrier to efficiency.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Soaring diesel prices are pushing Canada's truckers to the brink, threatening a fragile recovery and signaling higher costs for consumers on everything.

IPVanish launches Threat Protection Pro, moving beyond its VPN roots to offer a unified defense against malware, trackers, and phishing with enterprise tech.

UFS, BankOnIT, and others merge into Navanta, a new powerhouse aiming to simplify technology and empower over 700 community financial institutions.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

The Christopher Street Project’s massive rally on the National Mall united thousands to demand action and directly engage lawmakers on trans rights.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Private equity firm Kain Capital backs Florida's White Wilson Medical Center, appointing a new CEO to drive expansion and a shift to value-based care.